Skip to main content
. 2020 Mar 12;12(3):e7247. doi: 10.7759/cureus.7247

Table 2. Dosimetric results for the whole-breast plans (n = 23; prescribed dose: 42.5 Gy/16 fx).

SD: standard deviation; FB: free-breathing; DIBH: deep inspiration breath-hold; Tomo: tomotherapy; WH: whole heart; LAD: left anterior descending artery; V: percentage of volume receiving at least a given dose

  FB (mean ±SD) DIBH (mean ±SD) Tomo 1 (mean ±SD) Tomo 2 (mean ±SD)
WH        
Max (Gy) 43.5 ±0.5 31.6 ±12.3 35.0 ±5.0 28.0 ±8.2
Mean (Gy) 3.2 ±0.8 1.1 ±0.3 2.4 ±0.5 1.5 ±0.2
V20 (%) 5 ±2 0.5 ±0.7 1 ±1 0.2 ±0.3
LAD        
Max (Gy) 42.8 ±1.0 22.8 ±14.2 28.7 ±5.8 20.1 ±7.6
Mean (Gy) 27.0 ±6.3 8.0 ±7.6 13.7 ±4.1 6.6 ±2.4
Left lung        
Mean (Gy) 6.6 ±2.3 6.2 ±1.8 5.9 ±1.1 4.3 ±0.8
V5 (%) 22 ±7 23 ±6 30 ±5 21.9 ±4.0
V20 (%) 13 ±6 12 ±4 8 ±4 5 ±2
Right breast        
Max (Gy) 1.3 ±0.2 1.9 ±0.8 3.4 ±0.6 17.6 ±4.6
V3.1 (%) 0.0 ±0.0 0.0 ±0.0 0.1 ±0.4 33 ±15